BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

AFFiRiS AG 

Karl-Farkas-Gasse 22

Vienna    1030  Austria
Phone: 43-1-7981575-300 Fax: 43-1-7981575-311


SEARCH JOBS




Industry
Biotechnology

Segment
Biotechnology





 Company News
Breakthrough: AFFiRiS AG Claims A First In Alzheimer's Disease Therapy 6/5/2014 8:12:19 AM
AFFiRiS AG Release: Parkinson's Vaccine - Worldwide First Clinical Study in Vienna 6/5/2012 11:34:04 AM
AFFiRiS AG Inverts into Human Capital - Chief Business Officer Recruited 12/5/2011 11:29:18 AM
AFFiRiS AG: Capital Increase: AFFiRiS Brings Santo VC and MIG 11 on Board 11/8/2011 2:27:03 PM
Capital Increase: AFFiRiS AG Brings Santo VC and MIG 11 on Board 11/8/2011 10:00:14 AM
The Michael J. Fox Foundation Awards AFFiRiS AG $1.5 Million for the Clinical Development of the First Parkinson's Disease Vaccine 10/12/2011 10:15:51 AM
AFFiRiS AG: Alzheimer's Vaccination Shows Promising Results 3/11/2011 9:31:31 AM
AFFiRiS AG Announces an Extension of its Existing Alzheimer's Disease Vaccine Development Collaboration with GlaxoSmithKline (GSK) Triggering a Eur 3.5 Million Payment to Affiris 2/28/2011 10:56:45 AM
The Michael J. Fox Foundation Funds AFFiRiS AG to Develop Parkinson's Vaccine 12/16/2010 10:20:59 AM
AFFiRiS AG Alzheimer's Vaccine AD02 Already in Clinical Phase II 4/23/2010 10:09:52 AM